Joseph A. Chazan

1.2k total citations
37 papers, 837 citations indexed

About

Joseph A. Chazan is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Nutrition and Dietetics. According to data from OpenAlex, Joseph A. Chazan has authored 37 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Nutrition and Dietetics. Recurrent topics in Joseph A. Chazan's work include Renal function and acid-base balance (6 papers), Dialysis and Renal Disease Management (5 papers) and Cardiac Arrest and Resuscitation (5 papers). Joseph A. Chazan is often cited by papers focused on Renal function and acid-base balance (6 papers), Dialysis and Renal Disease Management (5 papers) and Cardiac Arrest and Resuscitation (5 papers). Joseph A. Chazan collaborates with scholars based in United States. Joseph A. Chazan's co-authors include Serafino Garella, Douglas Shemin, David D. Clark, Jorge E. Albina, J. Gary Abuelo, Alfredo R. Esparza, Steven P. Mistilis, Buris R. Boshell, Robert E. Stenson and George S. Kurland and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Joseph A. Chazan

36 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph A. Chazan United States 18 366 273 201 136 88 37 837
Robert E. Cronin United States 15 385 1.1× 274 1.0× 147 0.7× 222 1.6× 92 1.0× 28 921
Joan Blondin United States 14 356 1.0× 247 0.9× 292 1.5× 160 1.2× 55 0.6× 24 900
John F. Maher United States 17 718 2.0× 291 1.1× 192 1.0× 327 2.4× 93 1.1× 70 1.3k
G.A. Deveber Canada 14 405 1.1× 118 0.4× 183 0.9× 144 1.1× 45 0.5× 27 752
D.G. Oreopoulos Canada 15 681 1.9× 182 0.7× 313 1.6× 315 2.3× 50 0.6× 44 990
A. Cantaluppi Italy 15 600 1.6× 126 0.5× 229 1.1× 220 1.6× 41 0.5× 58 890
Stephen W. Zimmerman United States 23 792 2.2× 237 0.9× 207 1.0× 199 1.5× 129 1.5× 57 1.4k
J Montolíu Spain 17 266 0.7× 285 1.0× 88 0.4× 76 0.6× 102 1.2× 48 831
Jack Rubin United States 22 1.1k 2.9× 281 1.0× 311 1.5× 379 2.8× 76 0.9× 80 1.4k
Ramesh Naik United Kingdom 13 271 0.7× 111 0.4× 126 0.6× 164 1.2× 41 0.5× 29 538

Countries citing papers authored by Joseph A. Chazan

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Chazan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Chazan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Chazan more than expected).

Fields of papers citing papers by Joseph A. Chazan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Chazan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Chazan. The network helps show where Joseph A. Chazan may publish in the future.

Co-authorship network of co-authors of Joseph A. Chazan

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Chazan. A scholar is included among the top collaborators of Joseph A. Chazan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Chazan. Joseph A. Chazan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shemin, Douglas, et al.. (1999). Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. American Journal of Kidney Diseases. 34(1). 14–20. 88 indexed citations
2.
Chazan, Joseph A., et al.. (1995). Long-Term Survival of Vascular Accesses in a Large Chronic Hemodialysis Population. ˜The œNephron journals/Nephron journals. 69(3). 228–233. 88 indexed citations
3.
Chazan, Joseph A., et al.. (1992). The Impact of Diagnosis-Related Groups on the Cost of Hospitalization for End-Stage Renal Disease Patients at Rhode Island Hospital From 1987 to 1990. American Journal of Kidney Diseases. 19(6). 523–525. 11 indexed citations
4.
Abuelo, J. Gary, Douglas Shemin, & Joseph A. Chazan. (1992). Serum creatinine concentration at the onset of uremia: higher levels in black males.. PubMed. 37(6). 303–7. 12 indexed citations
5.
Esparza, Alfredo R., Joseph A. Chazan, Ramakrishna Nayak, & Tito Cavallo. (1991). Fibrillary (Immunotactoid) Glomerulopathy A Possible Role for Kappa Light Chain in Its Etiology and/or Pathogenesis. The American Journal of Surgical Pathology. 15(7). 632–643. 26 indexed citations
6.
Chazan, Joseph A.. (1991). Increased Serum Aluminum. Archives of Internal Medicine. 151(2). 319–319. 25 indexed citations
7.
Clark, David D., Jorge E. Albina, & Joseph A. Chazan. (1990). Subclavian Vein Stenosis and Thrombosis: A Potential Serious Complication in Chronic Hemodialysis Patients. American Journal of Kidney Diseases. 15(3). 265–268. 67 indexed citations
8.
Shemin, Douglas, et al.. (1990). Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure. The American Journal of Medicine. 89(4). 436–440. 33 indexed citations
9.
Crowley, James P., et al.. (1990). Lymphocyte subpopulations in long‐term dialysis patients: a case‐ controlled study of the effects of blood transfusion. Transfusion. 30(7). 644–647. 3 indexed citations
10.
Shemin, Douglas, et al.. (1989). Unexplained Pleural Effusions in the Peritoneal Dialysis Population. Peritoneal Dialysis International. 9(2). 143–143. 6 indexed citations
11.
Chazan, Joseph A., et al.. (1989). Plasma Aluminum Levels (Unstimulated and Stimulated): Clinical and Biochemical Findings in 185 Patients Undergoing Chronic Hemodialysis for 4 to 95 Months. American Journal of Kidney Diseases. 13(4). 284–289. 5 indexed citations
12.
Esparza, Alfredo R., Dianne B. McKay, John J. Cronan, & Joseph A. Chazan. (1989). Renal Parenchymal Malakoplakia. The American Journal of Surgical Pathology. 13(3). 225–236. 41 indexed citations
13.
Chazan, Joseph A.. (1988). Increased body aluminum. An independent risk factor in patients undergoing long-term hemodialysis?. Archives of Internal Medicine. 148(8). 1817–1820. 10 indexed citations
14.
Fauci, Anthony S., James E. Balow, Robert Brown, et al.. (1976). Successful renal transplantation in Wegener's granulomatosis. The American Journal of Medicine. 60(3). 437–440. 33 indexed citations
15.
Chazan, Joseph A.. (1974). Cornell Seminars in Nephrology. JAMA. 229(10). 1355–1355. 4 indexed citations
16.
Garella, Serafino, et al.. (1973). Severity of Metabolic Acidosis as a Determinant of Bicarbonate Requirements. New England Journal of Medicine. 289(3). 121–126. 77 indexed citations
17.
Cohen, John, Joseph A. Chazan, & Serafino Garella. (1970). The Interrelationship between ECF Volume and ECF Anion Composition in the Regulation of Sodium Excretion. Clinical Science. 39(4). 475–487. 3 indexed citations
18.
Chazan, Joseph A., et al.. (1970). Vascular Deposits Causing Ischemic Myopathy in Uremia. Annals of Internal Medicine. 73(1). 73–79. 10 indexed citations
19.
Chazan, Joseph A. & Buris R. Boshell. (1965). Etiological Factors in Thiazide-induced or Aggravated Diabetes Mellitus. Diabetes. 14(3). 132–136. 28 indexed citations
20.
Chazan, Joseph A. & Steven P. Mistilis. (1963). The pathophysiology of scurvy. The American Journal of Medicine. 34(3). 350–358. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Cronin Breakdown of academic impact, for papers by Joan Blondin Breakdown of academic impact, for papers by John F. Maher Breakdown of academic impact, for papers by G.A. Deveber Breakdown of academic impact, for papers by D.G. Oreopoulos Breakdown of academic impact, for papers by A. Cantaluppi Breakdown of academic impact, for papers by Stephen W. Zimmerman Breakdown of academic impact, for papers by J Montolíu Breakdown of academic impact, for papers by Jack Rubin Breakdown of academic impact, for papers by Ramesh Naik
Rankless by CCL
2026